carbamazepine has been researched along with Neurodegenerative Diseases in 3 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine (CBZ) is an antiepileptic drug, which also could be used in the treatment of neurodegenerative diseases, such as the Alzheimer's disease." | 7.88 | PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization. ( Alonso, SDV; Igartúa, DE; Martinez, CS; Prieto, MJ; Temprana, CF, 2018) |
| "Carbamazepine (CBZ) is an antiepileptic drug, which also could be used in the treatment of neurodegenerative diseases, such as the Alzheimer's disease." | 3.88 | PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization. ( Alonso, SDV; Igartúa, DE; Martinez, CS; Prieto, MJ; Temprana, CF, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Igartúa, DE | 1 |
| Martinez, CS | 1 |
| Temprana, CF | 1 |
| Alonso, SDV | 1 |
| Prieto, MJ | 1 |
| Tobin, WO | 1 |
| Mathur, SK | 1 |
| Saini, M | 1 |
| Bhardwaj, AK | 1 |
1 review available for carbamazepine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Management of Multiple Sclerosis Symptoms and Comorbidities.
Topics: Anticonvulsants; Carbamazepine; Cognitive Dysfunction; Comorbidity; Depression; Disease Management; | 2019 |
2 other studies available for carbamazepine and Neurodegenerative Diseases
| Article | Year |
|---|---|
PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization.
Topics: Animals; Carbamazepine; Cell Line; Cells, Cultured; Dendrimers; Drug Delivery Systems; Drug Liberati | 2018 |
The lady with a calcified brain.
Topics: Anticonvulsants; Basal Ganglia Diseases; Calcinosis; Calcium; Carbamazepine; Diagnosis, Differential | 2012 |